Anticoagulation therapy in COVID-19: Is there a dose-dependent benefit?
Título
Anticoagulation therapy in COVID-19: Is there a dose-dependent benefit?
Autor
Konstantinos G Kyriakoulis, Anastasios Kollias, Nikolaos K Syrigos, George S Stergiou
Fecha
2021
Materia
covid-19, Anti coagulation, survival, Dose, thromboprophylaxis
Identificador
10.1016/j.thromres.2020.12.013
Fuente
Thrombosis research
Archivos
Colección
Citación
Konstantinos G Kyriakoulis, Anastasios Kollias, Nikolaos K Syrigos, George S Stergiou, “Anticoagulation therapy in COVID-19: Is there a dose-dependent benefit?,” SOCICT Open, consulta 18 de abril de 2026, https://socictopen.socict.org/items/show/8459.
Position: 16083 (19 views)